Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
DNA synthesis inhibitor
DRUG CLASS:
DNA synthesis inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine-releasing intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
PCS3117 (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PTX-200 (0)
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine-releasing intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
PCS3117 (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PTX-200 (0)
›
Associations
(862)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Squamous Cell Carcinoma of Head and Neck
No biomarker
Squamous Cell Carcinoma of Head and Neck
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
No biomarker
Gastric Adenocarcinoma
No biomarker
Gastric Adenocarcinoma
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
No biomarker
Gastroesophageal Junction Adenocarcinoma
No biomarker
Gastroesophageal Junction Adenocarcinoma
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
cisplatin + docetaxel + 5-fluorouracil
Sensitive: A1 - Approval
cisplatin + docetaxel + 5-fluorouracil
Sensitive
:
A1
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
cisplatin + pemetrexed
Sensitive: A1 - Approval
cisplatin + pemetrexed
Sensitive
:
A1
cisplatin + pemetrexed
Sensitive: A1 - Approval
cisplatin + pemetrexed
Sensitive
:
A1
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
cisplatin + pemetrexed RTD
Sensitive: A1 - Approval
cisplatin + pemetrexed RTD
Sensitive
:
A1
cisplatin + pemetrexed RTD
Sensitive: A1 - Approval
cisplatin + pemetrexed RTD
Sensitive
:
A1
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
cytarabine/daunorubicin liposomal formulation
Sensitive: A1 - Approval
cytarabine / daunorubicin liposomal formulation
Sensitive
:
A1
cytarabine/daunorubicin liposomal formulation
Sensitive: A1 - Approval
cytarabine / daunorubicin liposomal formulation
Sensitive
:
A1
No biomarker
Testicular Cancer
No biomarker
Testicular Cancer
cisplatin
Sensitive: A1 - Approval
cisplatin
Sensitive
:
A1
cisplatin
Sensitive: A1 - Approval
cisplatin
Sensitive
:
A1
No biomarker
Astrocytoma
No biomarker
Astrocytoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Ependymoma
No biomarker
Ependymoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Medulloblastoma
No biomarker
Medulloblastoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Anaplastic Astrocytoma
No biomarker
Anaplastic Astrocytoma
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
No biomarker
Hodgkin Lymphoma
No biomarker
Hodgkin Lymphoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Non-Hodgkin’s Lymphoma
No biomarker
Non-Hodgkin’s Lymphoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Urothelial Cancer
No biomarker
Urothelial Cancer
mitomycin urothelial gel
Sensitive: A1 - Approval
mitomycin urothelial gel
Sensitive
:
A1
mitomycin urothelial gel
Sensitive: A1 - Approval
mitomycin urothelial gel
Sensitive
:
A1
No biomarker
Malignant Pleural Mesothelioma
No biomarker
Malignant Pleural Mesothelioma
cisplatin + pemetrexed
Sensitive: A1 - Approval
cisplatin + pemetrexed
Sensitive
:
A1
cisplatin + pemetrexed
Sensitive: A1 - Approval
cisplatin + pemetrexed
Sensitive
:
A1
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
No biomarker
Lung Non-Squamous Non-Small Cell Cancer
cisplatin + pemetrexed
Sensitive: A1 - Approval
cisplatin + pemetrexed
Sensitive
:
A1
cisplatin + pemetrexed
Sensitive: A1 - Approval
cisplatin + pemetrexed
Sensitive
:
A1
No biomarker
Pancreatic Adenocarcinoma
No biomarker
Pancreatic Adenocarcinoma
gemcitabine + albumin-bound paclitaxel
Sensitive: A1 - Approval
gemcitabine + albumin-bound paclitaxel
Sensitive
:
A1
gemcitabine + albumin-bound paclitaxel
Sensitive: A1 - Approval
gemcitabine + albumin-bound paclitaxel
Sensitive
:
A1
No biomarker
T Cell Non-Hodgkin Lymphoma
No biomarker
T Cell Non-Hodgkin Lymphoma
nelarabine
Sensitive: A1 - Approval
nelarabine
Sensitive
:
A1
nelarabine
Sensitive: A1 - Approval
nelarabine
Sensitive
:
A1
No biomarker
T Acute Lymphoblastic Leukemia
No biomarker
T Acute Lymphoblastic Leukemia
nelarabine
Sensitive: A1 - Approval
nelarabine
Sensitive
:
A1
nelarabine
Sensitive: A1 - Approval
nelarabine
Sensitive
:
A1
No biomarker
Acute Lymphocytic Leukemia
No biomarker
Acute Lymphocytic Leukemia
mercaptopurine
Sensitive: A1 - Approval
mercaptopurine
Sensitive
:
A1
mercaptopurine
Sensitive: A1 - Approval
mercaptopurine
Sensitive
:
A1
No biomarker
Bladder Cancer
No biomarker
Bladder Cancer
cisplatin
Sensitive: A1 - Approval
cisplatin
Sensitive
:
A1
cisplatin
Sensitive: A1 - Approval
cisplatin
Sensitive
:
A1
No biomarker
Glioma
No biomarker
Glioma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
temozolomide
Sensitive: A1 - Approval
temozolomide
Sensitive
:
A1
No biomarker
Glioblastoma
No biomarker
Glioblastoma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Multiple Myeloma
No biomarker
Multiple Myeloma
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
carmustine
Sensitive: A1 - Approval
carmustine
Sensitive
:
A1
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
cisplatin + docetaxel
Sensitive: A1 - Approval
cisplatin + docetaxel
Sensitive
:
A1
cisplatin + docetaxel
Sensitive: A1 - Approval
cisplatin + docetaxel
Sensitive
:
A1
No biomarker
Uveal Melanoma
No biomarker
Uveal Melanoma
melphalan hepatic delivery system
Sensitive: A1 - Approval
melphalan hepatic delivery system
Sensitive
:
A1
melphalan hepatic delivery system
Sensitive: A1 - Approval
melphalan hepatic delivery system
Sensitive
:
A1
No biomarker
Thyroid Gland Medullary Carcinoma
No biomarker
Thyroid Gland Medullary Carcinoma
dacarbazine
Sensitive: A2 - Guideline
dacarbazine
Sensitive
:
A2
dacarbazine
Sensitive: A2 - Guideline
dacarbazine
Sensitive
:
A2
No biomarker
Small Intestinal Carcinoma
No biomarker
Small Intestinal Carcinoma
gemcitabine + docetaxel
Sensitive: A2 - Guideline
gemcitabine + docetaxel
Sensitive
:
A2
gemcitabine + docetaxel
Sensitive: A2 - Guideline
gemcitabine + docetaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
cisplatin + paclitaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + paclitaxel + 5-fluorouracil
Sensitive
:
A2
cisplatin + paclitaxel + 5-fluorouracil
Sensitive: A2 - Guideline
cisplatin + paclitaxel + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
cisplatin + docetaxel
Sensitive: A2 - Guideline
cisplatin + docetaxel
Sensitive
:
A2
cisplatin + docetaxel
Sensitive: A2 - Guideline
cisplatin + docetaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
cisplatin
Sensitive: A2 - Guideline
cisplatin
Sensitive
:
A2
cisplatin
Sensitive: A2 - Guideline
cisplatin
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login